RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Cincinnati, OH · Cleveland, OH · Dayton, OH · +38 more sites
2 recruiting multiple sclerosis studies with a site in Dayton, OH.
Sponsor: TG Therapeutics, Inc.
Cincinnati, OH · Cleveland, OH · Dayton, OH · +38 more sites
Sponsor: University of Dayton
Dayton, OH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.